Invesco ChiNext 50 UCITS ETF Acc
| Issuer: Invesco |
| Asset Class: Equity |
| TER: 49bps |
| Trading Currency: USD |
| Pays Income: False |
| Listing Date: 21 Jun 2024 |
| Ticker: CN50 |
| ISIN: IE000AWRDWI7 |
This financial instrument offers targeted exposure to the ChiNext market of the Shenzhen Stock Exchange, often considered China's equivalent to the US NASDAQ. It focuses on the 50 largest and most liquid companies listed on this board, providing a snapshot of China's most innovative and fastest-growing sectors. The portfolio is heavily weighted towards high-growth areas such as industrial technology, healthcare, information technology, and consumer discretionary goods. By investing in these companies, one gains access to the core of China's strategic push towards technological self-sufficiency and a consumption-driven economy, moving beyond the traditional state-owned enterprises that dominate broader Chinese indices.
The strategy is designed for investors seeking to capture the high growth potential inherent in China's "new economy." These are the companies at the forefront of developing next-generation technologies and catering to the evolving demands of the nation's expanding middle class. However, this focus on growth comes with elevated risk. The ChiNext market can exhibit significantly higher volatility compared to more established markets, and investments are subject to the unique regulatory and geopolitical risks associated with China. Policy shifts from Beijing can have a sudden and substantial impact on these industries, making it a higher-risk, higher-reward proposition.
As a targeted thematic investment, this product is best suited for use as a satellite or tactical holding within a well-diversified global portfolio. It is appropriate for investors with a long-term investment horizon and a high tolerance for risk who are bullish on the long-term prospects of Chinese domestic innovation. The accumulating share class structure ensures that any dividends paid by the underlying companies are automatically reinvested, which can enhance the effects of compounding over time, aligning well with a long-term growth objective.
